Seth J. Zost

8.9k total citations · 6 hit papers
20 papers, 2.5k citations indexed

About

Seth J. Zost is a scholar working on Epidemiology, Infectious Diseases and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Seth J. Zost has authored 20 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Epidemiology, 10 papers in Infectious Diseases and 6 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Seth J. Zost's work include Influenza Virus Research Studies (10 papers), SARS-CoV-2 and COVID-19 Research (7 papers) and Respiratory viral infections research (7 papers). Seth J. Zost is often cited by papers focused on Influenza Virus Research Studies (10 papers), SARS-CoV-2 and COVID-19 Research (7 papers) and Respiratory viral infections research (7 papers). Seth J. Zost collaborates with scholars based in United States, Germany and Australia. Seth J. Zost's co-authors include Scott E. Hensley, James E. Crowe, Michael Diamond, Kaela Parkhouse, Laura A. VanBlargan, Robert H. Carnahan, Pavlo Gilchuk, Rachel E. Sutton, Patrick C. Wilson and Sarah Cobey and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Seth J. Zost

20 papers receiving 2.4k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody Recognition

2020 568 citations Allison J. Greaney, Tyler N. Starr et al. Cell Host & Microbe profile →
An infectious SARS-CoV-2 B.1.1.529 Omicron virus escapes neutralization by therapeutic monoclonal antibodies

2022 423 citations Laura A. VanBlargan, John M. Errico et al. Nature Medicine profile →
Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains

2017 399 citations Seth J. Zost, Kaela Parkhouse et al. Proceedings of the National Academy of Sciences profile →
Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein

2021 215 citations Naveenchandra Suryadevara, Swathi Shrihari et al. Cell profile →
Nucleoside-modified mRNA immunization elicits influenza virus hemagglutinin stalk-specific antibodies

2018 201 citations Norbert Pardi, Kaela Parkhouse et al. Nature Communications profile →
Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protection

2021 183 citations Emma S. Winkler, Pavlo Gilchuk et al. Cell profile →

Peers

Countries citing papers authored by Seth J. Zost

Since Specialization

Citations

This map shows the geographic impact of Seth J. Zost's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Seth J. Zost with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Seth J. Zost more than expected).

Fields of papers citing papers by Seth J. Zost

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Seth J. Zost. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Seth J. Zost. The network helps show where Seth J. Zost may publish in the future.

Co-authorship network of co-authors of Seth J. Zost

This figure shows the co-authorship network connecting the top 25 collaborators of Seth J. Zost. A scholar is included among the top collaborators of Seth J. Zost based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Seth J. Zost. Seth J. Zost is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Imprinting of serum neutralizing antibodies by Wuhan-1 mRNA vaccines 2024 ·Nature ·Chieh-Yu Liang, Saravanan Raju, Zhuoming Liu, Yuhao Li, Guha Asthagiri Arunkumar, James Brett Case, Suzanne M. Scheaffer, Seth J. Zost, (unknown), Matthew Gagné, Shayne F. Andrew, (unknown), Kathryn E. Foulds, Jason S. McLellan, James E. Crowe, Daniel C. Douek, Sean P. J. Whelan, Sayda M. Elbashir, Darin K. Edwards, Michael Diamond	25
2	SARS-CoV-2 antibodies from children exhibit broad neutralization and belong to adult public clonotypes 2023 ·Cell Reports Medicine ·(unknown), Naveenchandra Suryadevara, Chang-Il Kim, Andrea R. Shiakolas, (unknown), (unknown), (unknown), (unknown), Elad Binshtein, Elaine C. Chen, Seth J. Zost, (unknown), James E. Crowe, (unknown), Daniel J. Sheward, Robert H. Carnahan, Ivelin S. Georgiev	6
3	An infectious SARS-CoV-2 B.1.1.529 Omicron virus escapes neutralization by therapeutic monoclonal antibodies breakdown → 2022 ·Nature Medicine ·Laura A. VanBlargan, John M. Errico, Peter Halfmann, Seth J. Zost, James E. Crowe, Lisa A. Purcell, Yoshihiro Kawaoka, Davide Corti, Daved H. Fremont, Michael Diamond	423
4	Real-time cell analysis: A high-throughput approach for testing SARS-CoV-2 antibody neutralization and escape 2022 ·STAR Protocols ·Naveenchandra Suryadevara, Pavlo Gilchuk, Seth J. Zost, Nikhil Mittal, (unknown), James E. Crowe, Robert H. Carnahan	7
5	An Egg-Derived Sulfated N -Acetyllactosamine Glycan Is an Antigenic Decoy of Influenza Virus Vaccines 2021 ·mBio ·Jenna J. Guthmiller, Henry A. Utset, Carole Henry, Lei Li, Nai‐Ying Zheng, Weina Sun, Marcos C. Vieira, Seth J. Zost, Min Huang, Scott E. Hensley, Sarah Cobey, Peter Palese, Patrick C. Wilson	9
6	Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protection breakdown → 2021 ·Cell ·Emma S. Winkler, Pavlo Gilchuk, Jinsheng Yu, Adam L. Bailey, Rita E. Chen, Zhenlu Chong, Seth J. Zost, Hyesun Jang, Ying Huang, James D. Allen, James Brett Case, Rachel E. Sutton, Robert H. Carnahan, Tamarand L. Darling, Adrianus C. M. Boon, Matthias Mack, Richard D. Head, Ted M. Ross, James E. Crowe, Michael Diamond	183
7	Pan-ebolavirus protective therapy by two multifunctional human antibodies 2021 ·Cell ·Pavlo Gilchuk, Charles D. Murin, Robert W. Cross, Philipp A. Ilinykh, Kai Huang, Natalia A. Kuzmina, Viktoriya Borisevich, Krystle N. Agans, Joan B. Geisbert, Seth J. Zost, Rachel S. Nargi, Rachel E. Sutton, Naveenchandra Suryadevara, Robin Bombardi, Robert H. Carnahan, Alexander Bukreyev, Thomas W. Geisbert, Andrew B. Ward, James E. Crowe	23
8	The Crossroads of Glycoscience, Infection, and Immunology 2021 ·Frontiers in Microbiology ·Tanya R. McKitrick, Margaret E. Ackerman, Robert M. Anthony, Clay S. Bennett, Michael Demetriou, Gregory A. Hudalla, Katharina Ribbeck, Stefan Rühl, Christina M. Woo, (unknown), Seth J. Zost, Ronald L. Schnaar, Tamara L. Doering	6
9	Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein breakdown → 2021 ·Cell ·Naveenchandra Suryadevara, Swathi Shrihari, Pavlo Gilchuk, Laura A. VanBlargan, Elad Binshtein, Seth J. Zost, Rachel S. Nargi, Rachel E. Sutton, Emma S. Winkler, Elaine C. Chen, Mallorie E. Fouch, Edgar Davidson, Benjamin J. Doranz, Rita E. Chen, Pei‐Yong Shi, Robert H. Carnahan, Larissa B. Thackray, Michael Diamond, James E. Crowe	215
10	Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein 2021 ·The Journal of Immunology ·Naveenchandra Suryadevara, Swathi Shrihari, Pavlo Gilchuk, Laura A. VanBlargan, Elad Binshtein, Seth J. Zost, Rachel S. Nargi, Rachel E. Sutton, Emma S. Winkler, Elaine C. Chen, Mallorie E. Fouch, Edgar Davidson, Benjamin J. Doranz, Robert H. Carnahan, Larissa B. Thackray, Michael Diamond, James E. Crowe	5
11	Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody Recognition breakdown → 2020 ·Cell Host & Microbe ·Allison J. Greaney, Tyler N. Starr, Pavlo Gilchuk, Seth J. Zost, Elad Binshtein, Andrea N. Loes, Sarah K. Hilton, John Huddleston, Rachel Eguia, Katharine H. D. Crawford, Adam S. Dingens, Rachel S. Nargi, Rachel E. Sutton, Naveenchandra Suryadevara, Paul W. Rothlauf, Zhuoming Liu, Sean P. J. Whelan, Robert H. Carnahan, James E. Crowe, Jesse D. Bloom	568
12	Identification of Antibodies Targeting the H3N2 Hemagglutinin Receptor Binding Site following Vaccination of Humans 2019 ·Cell Reports ·Seth J. Zost, Juhye Lee, Megan E. Gumina, Kaela Parkhouse, Carole Henry, Nicholas C. Wu, Chang‐Chun D. Lee, Ian A. Wilson, Patrick C. Wilson, Jesse D. Bloom, Scott E. Hensley	23
13	Mapping person-to-person variation in viral mutations that escape polyclonal serum targeting influenza hemagglutinin 2019 ·eLife ·Juhye Lee, Rachel Eguia, Seth J. Zost, Saket Choudhary, Patrick C. Wilson, Trevor Bedford, Terry Stevens‐Ayers, Michael Boeckh, Aeron C. Hurt, Seema S. Lakdawala, Scott E. Hensley, Jesse D. Bloom	61
14	Identification of Antibodies Targeting the H3N2 Hemagglutinin Receptor Binding Site Following Vaccination of Humans 2019 ·SSRN Electronic Journal ·Seth J. Zost, Juhye Lee, Megan E. Gumina, Kaela Parkhouse, Carole Henry, Jesse D. Bloom, Scott E. Hensley	1
15	Comparison of Human H3N2 Antibody Responses Elicited by Egg-Based, Cell-Based, and Recombinant Protein–Based Influenza Vaccines During the 2017–2018 Season 2019 ·Clinical Infectious Diseases ·Sigrid Gouma, Seth J. Zost, Kaela Parkhouse, Angela R Branche, David J. Topham, Sarah Cobey, Scott E. Hensley	27
16	Human Influenza A Virus Hemagglutinin Glycan Evolution Follows a Temporal Pattern to a Glycan Limit 2019 ·mBio ·Meghan O. Altman, Matthew Angel, Ivan Košík, Nídia S. Trovão, Seth J. Zost, James S. Gibbs, Lorenzo Casalino, Rommie E. Amaro, Scott E. Hensley, Martha I. Nelson, Jonathan W. Yewdell	70
17	Nucleoside-modified mRNA immunization elicits influenza virus hemagglutinin stalk-specific antibodies breakdown → 2018 ·Nature Communications ·Norbert Pardi, Kaela Parkhouse, Ericka Kirkpatrick, Meagan McMahon, Seth J. Zost, Barbara L. Mui, Ying K. Tam, Katalin Karikó, Christopher Barbosa, Thomas D. Madden, Michael J. Hope, Florian Krammer, Scott E. Hensley, Drew Weissman	201
18	Immunodominance and Antigenic Variation of Influenza Virus Hemagglutinin: Implications for Design of Universal Vaccine Immunogens 2018 ·The Journal of Infectious Diseases ·Seth J. Zost, Nicholas C. Wu, Scott E. Hensley, Ian A. Wilson	67
19	Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains breakdown → 2017 ·Proceedings of the National Academy of Sciences ·Seth J. Zost, Kaela Parkhouse, Megan E. Gumina, Kangchon Kim, (unknown), Patrick C. Wilson, John J. Treanor, Andrea J. Sant, Sarah Cobey, Scott E. Hensley	399
20	A structural explanation for the low effectiveness of the seasonal influenza H3N2 vaccine 2017 ·PLoS Pathogens ·Nicholas C. Wu, Seth J. Zost, Andrew J. Thompson, David Oyen, Corwin M. Nycholat, Ryan McBride, James C. Paulson, Scott E. Hensley, Ian A. Wilson	175

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact